IBIO Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
-100.0%
100.0K
-50.0%
200.0K
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
-100.0%
100.0K
-50.0%
200.0K
0
Operating Expenses
8.4M
0
-100.0%
6.1M
+12.1%
5.4M
+10.6%
4.9M
R&D
3.3M
0
-100.0%
3.5M
+10.1%
3.2M
+69.2%
1.9M
SG&A
5.1M
0
-100.0%
2.5M
+15.0%
2.2M
-26.9%
3.0M
Operating Income
-8365000
0
+100.0%
-5951000
-14.5%
-5198000
-6.5%
-4879000
EBITDA
-8213000
0
+100.0%
-5823000
-10.4%
-5275000
-11.0%
-4753000
Net Income
-7761000
0
+100.0%
-5720000
-10.8%
-5163000
-6.2%
-4861000
EPS (Basic)
$-0.06
$0.00
+100.0%
$-0.11
+69.4%
$-0.36
+26.5%
$-0.49
EPS (Diluted)
$-0.06
$0.00
+100.0%
$-0.11
+69.4%
$-0.36
+26.5%
$-0.49
Shares (Diluted)
119.6M
0
-100.0%
53.0M
+268.7%
14.4M
+45.7%
9.9M
iBio (IBIO) โ€” Financials